PHARMACOLOGICAL EFFICACY OF AN INHIBITOR OF ARGINASE-2 KUD975 WITH L-NAME-INDUCED ENDOTHELIAL DYSFUNCTION
The study of endotelio- and cardioprotective activity of finished dosage forms - tablets, film-coated, containing 10 mg of phenolic nature KUD-975, was shown a statistically significant decrease in blood pressure and the coefficient of endothelial dysfunction on the background of simulation L-NAME-i...
Saved in:
Main Authors: | Konstantin Kudryavtsev (Author), Michael Korokin (Author), Oleg Gudyrev (Author) |
---|---|
Format: | Book |
Published: |
Belgorod National Research University,
2017-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correction of morphofunctional disorders with asialoerythropoietin and selective inhibitor of arginase II KUD975 in cases of ischemic kidney damage in the experiment
by: Vladislav Elagin, et al.
Published: (2018) -
Study of the effect of acetylsalicylic acid and a selective arginase II inhibitor KUD 975 on the correction of hemostatic disorders in experimental preeclampsia
by: Anastasia V. Gureeva, et al.
Published: (2022) -
Study of the effect of selective inhibitor of Arginase II KUD 975 and of low doses of Acetylsalicylic acid on the functional parameters of the cardiovascular system In experimental preeclampsia
by: Olga V. Severinova, et al.
Published: (2019) -
The role of arginase in endothelial dysfunction
by: Rudolf Lucas
Published: (2015) -
Correction of morphofunctional disorders of the cardiovascular system with asialized erythropoietin and arginase II selective inhibitors KUD 974 and KUD 259 in experimental preeclampsia
by: Tatyana I. Lokteva, et al.
Published: (2020)